The present invention relates to agonists of the human bitter-taste
receptors hTAS2R14, hTAS2R10 and hTAS2R4 and their role in bitter taste
transduction. The invention also relates to methods for identifying
molecules that modulate, e.g. suppress, or enhance hTAS2R14, hTAS2R10 and
hTAS2R4 bitter taste transduction or bitter taste response.